-
Phenacetin for PK Assay Design and Troubleshooting
2026-08-13
Learn how Phenacetin can support controlled solubility, stability, and pharmacokinetic method development without confusing an analytical benchmark with a therapeutic claim. This workflow emphasizes solvent control, matrix recovery, reference-compound discipline, and practical troubleshooting for scientific research use.
-
Benzyl-activated Streptavidin Magnetic Beads K1301
2026-08-13
K1301 provides magnetically recoverable streptavidin for capturing biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from complex samples. It is appropriate for benchtop purification, immunoprecipitation, interaction assays, and screening workflows, but non-biotinylated targets require a validated biotinylation or indirect-capture strategy.
-
SERF as a Modifier of Amyloid Formation
2026-08-12
The reference dissertation investigates SERF as a regulator of amyloid formation rather than treating aggregation as a purely intrinsic property of the substrate protein. Its combination of molecular engineering, protein fractionation, electrophoretic analysis, and yeast-based assays provides a framework for connecting amyloid biophysics with cellular protein homeostasis while highlighting the limits of transferring in vitro observations to living systems.
-
DiscoveryProbe FDA-approved Drug Library for Gectosomes
2026-08-12
Use the DiscoveryProbe FDA-approved Drug Library to map how clinically approved compounds influence CNV-G gectosome production, cell entry, and intracellular cargo activity. This workflow combines drug repositioning screening with high-content phenotyping to distinguish delivery enhancers from uptake, toxicity, and fluorescence artifacts.
-
Phosphoproteomic Adaptation to Cabozantinib in RCC
2026-08-11
This 2026 reference study distinguishes acute from chronic Cabozantinib exposure by integrating quantitative phosphoproteomics with migration and invasion assays in renal cell carcinoma. Its central finding is that prolonged treatment does not simply restore MET signaling; instead, it produces selective adhesion-, stress-, and MAPK/AP-1-associated remodeling alongside pattern-specific motility changes.
-
Ridaforolimus for mTOR and Senescence Assays
2026-08-11
Ridaforolimus, also called Deforolimus or MK-8669, offers a practical way to connect mTOR target engagement with proliferation, apoptosis, VEGF, and senescence-focused readouts. This workflow emphasizes dose selection, orthogonal validation, and careful interpretation when using the compound as a pathway perturbation tool rather than assuming every growth response is senolytic.
-
EDC.HCl: Practical Coupling Workflow
2026-08-10
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for in vitro amide-bond formation in peptide synthesis, bioconjugation, and related workflows. It should be handled as a laboratory coupling reagent only; no in vivo or clinical data are available, and reaction conditions require local experimental validation.
-
Batimastat (BB-94): Mapping MMP-Driven BDNF
2026-08-09
Batimastat (BB-94) can do more than suppress matrix metalloproteinase activity: it can help separate extracellular proteolysis from intracellular BDNF processing. This article connects spatial neuromuscular-junction biology with preclinical tumor models while emphasizing assay interpretation, controls, and evidence limits.
-
Measuring Cancer Drug Responses In Vitro
2026-08-08
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer response. Its central contribution is a framework for separating growth inhibition from cell killing, improving interpretation of drug effects and the design of in vitro cancer studies.
-
Mac-1 Deficiency Reduces Cardiac Remodeling in Pressure Over
2026-08-07
This study demonstrates that Mac-1 deficiency significantly protects against heart failure induced by pressure overload in mice, primarily by inhibiting macrophage infiltration and polarization. These findings provide new insight into immune-mediated mechanisms of pathological cardiac remodeling and highlight potential therapeutic strategies for heart failure.
-
Catalpol Attenuates Liver Fibrosis by Modulating Glycolysis
2026-08-06
This study identifies catalpol as a direct inhibitor of the EphA2/FAK/Src signaling pathway, resulting in suppressed aerobic glycolysis and reduced activation of hepatic stellate cells (HSCs) during liver fibrosis. The findings provide mechanistic insight into targeting metabolic reprogramming for anti-fibrotic intervention.
-
TAK-715 and the New Era of Dual-Action p38α Inhibition
2026-08-06
This thought-leadership article explores TAK-715 as a next-generation, dual-action p38 MAPK inhibitor. We integrate recent mechanistic insights into kinase-phosphatase interplay, present actionable guidance for translational researchers, and situate TAK-715 within the evolving anti-inflammatory research landscape. Drawing on cutting-edge structural biology and translational models, we highlight how selective p38α inhibition, coupled with enhanced dephosphorylation, is redefining cytokine signaling modulation and chronic disease research.
-
Light-Inducible RNA Switches Enable Precision Gene Therapy C
2026-08-05
A new study introduces a rationally engineered light-inducible RNA-releasing protein (LIRP) that enables precise, reversible control of therapeutic gene expression in vivo. This optogenetic system advances translational regulation and safety for gene therapy, with demonstrated efficacy in metabolic and retinal disease models.
-
KX2-391 Dihydrochloride: Strategic Leverage in Translational
2026-08-05
This article presents a thought-leadership perspective on KX2-391 dihydrochloride (Tirbanibulin dihydrochloride), blending mechanistic detail with actionable insights for translational researchers. We explore its dual action on Src kinase and tubulin, recent SAR findings, and its value in bridging oncology, virology, and neurotoxin research. Evidence-driven guidance and protocol parameters are provided, alongside a critical outlook on clinical and experimental frontiers.
-
Surfactant-Derived Lipid Nanoparticles Enable mRNA Delivery
2026-08-04
The referenced study demonstrates a novel dual-component lipid nanoparticle (LNP) system for efficient intracellular delivery of messenger RNA to macrophages. By leveraging surfactant-derived ionizable lipids without PEGylated components, the LNPs achieve high mRNA encapsulation, biocompatibility, and effective gene expression, offering new strategies for non-viral macrophage genetic engineering.